Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: UK's Unilabs-HIS to Provide Roche HPV Test

Premium

Roche said this week that it has signed a co-marketing deal with London-based pathology and molecular diagnostic lab Unilabs-IHS to provide Roche's Cobas HPV test to women in the UK.

Unilabs will provide the test as a follow-up to traditional Pap cervical smears and, upon request, as a primary screen for cervical pre-cancer.

The Cobas HPV test runs on the company's Cobas 4800 automated molecular testing system and individually identifies genotypes 16 and 18, the highest risk types associated with the development of cervical cancer and its precursor lesions, as well as 12 other high-risk HPV types as a pooled result.

Roche launched the assay in 2009 in countries that accept the CE Mark. The US Food and Drug Administration cleared the assay for marketing in April 2011.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.